Pre-Test Harnessing the Utility of Selective Sphingosine 1-Phosphate Receptor Modulators to Optimize Patient Care in IBD Pre-Test S1PR modulators indirectly antagonize the receptor’s function leading to which of the following? Decreased peripheral circulation of cells involved in immune surveillance (eg, monocytes and NK cells) Increased peripheral circulation of cells involved in immune surveillance (eg, monocytes and NK cells) Sequestration of lymphocytes in the lymph nodes, reducing circulating lymphocyte counts Sequestration of lymphocytes within inflamed tissue, reducing circulating lymphocyte counts Unsure In a recent open-label extension study, approximately half of the patients with moderate to severe UC who did not meet clinical response after 10 weeks of ozanimod therapy benefited from an additional ______ weeks of ozanimod therapy. 2-5 5-10 10-15 15-20 Unsure How confident are you in your ability to incorporate emerging therapies into IBD management strategies to address suboptimal outcomes in appropriate patients? Very Confident Confident Somewhat confident Not very confident Not at all confident
